IL112497A0 - Drug - Google Patents

Drug

Info

Publication number
IL112497A0
IL112497A0 IL11249795A IL11249795A IL112497A0 IL 112497 A0 IL112497 A0 IL 112497A0 IL 11249795 A IL11249795 A IL 11249795A IL 11249795 A IL11249795 A IL 11249795A IL 112497 A0 IL112497 A0 IL 112497A0
Authority
IL
Israel
Prior art keywords
active ingredient
aids
sweat
contg
water
Prior art date
Application number
IL11249795A
Other languages
English (en)
Original Assignee
Drossapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drossapharm Ag filed Critical Drossapharm Ag
Publication of IL112497A0 publication Critical patent/IL112497A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
IL11249795A 1994-02-18 1995-01-31 Drug IL112497A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH49594 1994-02-18

Publications (1)

Publication Number Publication Date
IL112497A0 true IL112497A0 (en) 1995-03-30

Family

ID=4188315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11249795A IL112497A0 (en) 1994-02-18 1995-01-31 Drug

Country Status (17)

Country Link
US (1) US5750139A (fr)
EP (1) EP0668074B1 (fr)
JP (1) JPH0834729A (fr)
KR (1) KR950031040A (fr)
CN (1) CN1113434A (fr)
AT (1) ATE200979T1 (fr)
AU (1) AU1221395A (fr)
BR (1) BR9500681A (fr)
CA (1) CA2142315A1 (fr)
CZ (1) CZ35095A3 (fr)
DE (1) DE59509232D1 (fr)
FI (1) FI950737A (fr)
HU (1) HUT72887A (fr)
IL (1) IL112497A0 (fr)
NO (1) NO950605L (fr)
PL (1) PL307326A1 (fr)
ZA (1) ZA951111B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302638B1 (it) * 1998-10-09 2000-09-29 A C R Applied Coating Res Sa Cerotti transdermici a base di cumarina o meliloto
DE60113569T2 (de) * 2001-12-04 2006-05-04 Mac Pharma S.A.S. Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
CN107929239B (zh) * 2010-10-28 2021-06-01 阿尔法缇欧米茄制药咨询有限公司 阿立哌唑组合物和用于其经皮给药的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142913A (en) * 1981-02-27 1982-09-03 Nitto Electric Ind Co Ltd Donor of physiologically active substance
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
AU575930B2 (en) * 1984-03-01 1988-08-11 Hamilton Laboratories Pty. Ltd. Treatment of high protein oedemas in animals
KR970008118B1 (ko) * 1987-07-09 1997-05-21 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 피부 침투성 치료 시스템
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5525626A (en) * 1989-11-24 1996-06-11 Schaper & Bruemmer Gmbh & Co. Treating susceptible human malignant tumors with 7-hydroxy-1,2-benzopyrone
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5424320A (en) * 1993-06-23 1995-06-13 Merck Frosst Canada, Inc. Heteroaryl coumarins as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
AU1221395A (en) 1995-08-31
JPH0834729A (ja) 1996-02-06
ZA951111B (en) 1995-10-16
DE59509232D1 (de) 2001-06-13
NO950605D0 (no) 1995-02-17
US5750139A (en) 1998-05-12
EP0668074B1 (fr) 2001-05-09
HU9500221D0 (en) 1995-03-28
CZ35095A3 (en) 1995-10-18
NO950605L (no) 1995-08-21
KR950031040A (ko) 1995-12-18
ATE200979T1 (de) 2001-05-15
PL307326A1 (en) 1995-08-21
BR9500681A (pt) 1995-10-24
FI950737A (fi) 1995-08-19
CN1113434A (zh) 1995-12-20
HUT72887A (en) 1996-06-28
EP0668074A1 (fr) 1995-08-23
CA2142315A1 (fr) 1995-08-19
FI950737A0 (fi) 1995-02-17

Similar Documents

Publication Publication Date Title
IE790756L (en) Cerebral therapeutic agent
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
ES2171165T3 (es) Dispositivo bioerosionable para la administracion de agentes activos.
ATE324865T1 (de) Hautpenetrationsförderer sowie diese verwendende arzneiverabreichungssysteme
ES2183839T3 (es) Composiciones y procedimiento de reparacion y de prevencion de lesiones del tipo de fibrosis.
ZA866917B (en) Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same
CA2257172A1 (fr) Oxydes solubles pour applications biologiques
EP0882450A3 (fr) Composition contenant la coenzyme Q pour réduire le taux de cholesterol
EP0834320A4 (fr) Composition de medicament comprenant de l'albumine en tant que principe actif
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
CA2031817A1 (fr) Utilisation de la thrombospondine pour favoriser la cicatrisation
AU3324100A (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
IL112497A0 (en) Drug
NZ224957A (en) Optionally heterocyclically-substituted oxazolidin-2-one derivatives
CA2340734A1 (fr) Derive de pyridyl-4h-1,2,4-oxadiazine optiquement actif et son utilisation dans le traitement des maladies vasculaires
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
CA2091134A1 (fr) Agent therapeutique contre les risques d'avortement
FR2613617B1 (fr) Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine
IT1214658B (it) Esteri polisaccaridici e loro sali
CA2288966A1 (fr) Medicaments de prevention ou de traitement de la recto-colite hemorragique et/ou de la maladie de crohn
Mehra et al. Role of tromaril--a new anti-inflammatory drug in eye diseases
AU1783699A (en) Compositions for the transdermal and dermal administration of biologically active agents
IE43848L (en) Pharmaceutical compositions
CA2186752A1 (fr) Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps